Disease activity state by ASDAS-CRP vs. ASDAS-qCRP (A) and ASDAS-CRP

Disease activity categories by ASDAS-qCRP vs. ASDAS-CRP

Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study - Fabian Proft, Julia Schally, Henning Christian Brandt, Jan Brandt-Juergens, Gerd

Validation of the Disease Activity Index for PSoriatic Arthritis (DAPSA) with a quick quantitative C-reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis (PsA) - GRAPPA Network

Discrimination: standardized mean difference in ASDAS scores between

PDF) Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this?

The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry - Jinhyun Kim, Min Jung Kim, Geun Young Oh, Sun Kyung Lee

PDF) Measuring disease activity in ankylosing spondylitis: Patient and physician have different perspectives

Figure 3, Quick ASDAS-CRP Calculation Form - Upadacitinib (Rinvoq) - NCBI Bookshelf

Change from baseline to week 12 in patient-reported outcomes by ASDAS

PDF) Validation of the ASDAS with a quick quantitative CRP assay (ASDAS-Q) in patients with axial SpA: a prospective multicentre cross-sectional study

Discrimination: standardized mean difference in ASDAS scores between

FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining the Best Calculation Method When the Conventional C-Reactive Protein (CRP) is below the Threshold of Detection - Results from the DESIR Cohort

PDF) Ankylosing Spondylitis Disease Activity Score (ASDAS): Defining cut-off values for disease activity states and improvement scores

PDF) The predictability of ASDAS on drug survival in patients with ankylosing spondylitis on biologic therapy: data from the KOBIO registry